NLS Global report

With the agreement, the Novo Nordisk Foundation expands its existing collaboration with WHO, committing to a granting frame of up to DKK 380 million over the next four years.

The companies have entered into an agreement for the global co-development and co-commercialization of BioNTech’s investigational bispecific antibody BNT327 across numerous solid tumor types.

Opdivo is the first and only PD-1 inhibitor approved for subcutaneous (SC) use in the European Union.

The European Commission has launched the EU Startup and Scaleup Strategy, ‘Choose Europe to Start and Scale', to make Europe a great place to start and grow global technology-driven companies.

The decision by the 78th World Health Assembly culminates more than three years of intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic.

Kristi Noem, Homeland Security Secretary, stated that the administration had revoked Harvard's "Student and Exchange Visitor Program certification as a result of their failure to adhere to the law."